The global ligament augmentation market enjoys a valuation of US$ 45.7 million in 2023. The market is projected to expand at a CAGR of 5.8% over the forecast years, totaling US$ 80.3 million by 2033. The increasing incidence of injuries and the growing popularity of ligament augmentation for treating injured ligaments and protecting them from reinjury after surgery are some of the key factors driving demand for ligament augmentation.
Emerging trends reveal that the artificial tendons and ligaments segment is likely to lead the global market, accounting for about 61.6% in 2023.
One of the six ligaments that stabilize the human knee joint during articulations is the anterior cruciate ligament (ACL). It is more prone to acute and long-term damage than other ligaments.
An ACL injury requires time-consuming repair and self-healing measures. Surgical repair or replacement is necessary for personnel who want to resume an active sports life. Osteoarthritis frequently develops as a result of untreated ACL tears.
The discovery that biological grafts go through a phase of degradation and loss of strength before being incorporated gave credence to the emergence of ligament augmentation. During this vulnerable phase, the ligament augmentation procedure with artificial tendons, ligaments, and ligament augmentation devices is designed to safeguard the biological transplant.
Currently, the global ligament augmentation market holds around 4.1% share of the overall global collateral ligament stabilizer system market with an approximate value of around US$ 1.3 Billion.
| Attribute | Key Statistics |
|---|---|
| Ligament Augmentation Market Base Value (2023) | US $ 45.7 million |
| Projected Market Valuation (2033) | US$ 80.3 million |
| Value-based CAGR (2023 to 2033) | 5.8% |
| Market Share of Top 5 Countries | 45.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global sales of the ligament augmentation market are anticipated to rise at a CAGR of 5.8% between 2023 and 2033, owing to the increased awareness of ACL procedures and increasing sports-related injuries.
One of the key factors propelling the growth in the market is the increase in sports injuries that cause damage to ligaments and tendons.
Ligament augmentation procedures call for augmentation tools in conjunction with synthetic tissue to replace natural tissues. As pathological wear and tear of the connective tissue is increasingly common among older people, the surge in the geriatric population will eventually expand the global ligament augmentation market size during the forecast period.
Similarly, the growing popularity of minimally invasive techniques is expected to push the demand for ligament augmentation over the next ten years.
Regional governments are taking measures to inform the general public about treatments, which is another factor fueling the global market expansion.
Research and development on medical devices that are simple to use, quick to recuperate following surgery, and less likely to cause complications afterward are growing as the healthcare market expands its potential for technologically enhanced medical and surgical devices. This aspect will support the expansion of the globe during the assessment period.
Owing to the factors mentioned above, the global market is expected to grow at a lucrative pace, reaching a valuation of around US$ 80.3 million by 2033.
Higher Success Rate of Ligament Augmentation Bolstering Market Growth
The market for ligament augmentation is anticipated to expand due to increasing recognition of the procedure's success rates for replacing a torn or ruptured ligament or tendon with an artificial material and the surge in sports injuries, particularly in the United States and China.
These nations have made a major contribution to the market share of these procedures. As per the American Academy of Orthopaedic Surgeons, an estimated 126.6 million Americans (or one in two adults) suffer from a musculoskeletal condition (2016). Estimates are increasing due to greater sports participation and an increasingly aging demographic.
The ligament augmentation process shortens surgery and recovery time. Because of technological improvements and reliability, it aids in enhancing the clinical prospects of innovative procedures performed by skilled surgeons.
Another significant factor driving the market growth is the limitations of autografts and allografts. Tendon rupture, joint and muscle weakness, pain, and loss of mobility are frequent side complications of artificial ligament and tendon replacement employing autograft and allograft.
Principal Consultant
The market for ligament augmentation is expected to grow due to awareness campaigns and technological improvements. However, some elements may limit its capacity to expand.
These surgical procedures are exorbitant because they use high-tech medical equipment. To use them, surgeons also need precise capabilities. Due to the increase in surgical treatment costs, not everybody who requires it can afford it.
Studies show that since ligament augmentation includes surgery, regardless of how sophisticated the technology, there is always a chance that it will result in post-operative complications of the tissues, such as a foreign body reaction in the synovial membranes, particularly in the elderly population due to the insertion of foreign material into the body, which can have a negative outcome.
Professionals with expertise are also essential for such surgical interventions. Thus, the dearth of these qualified surgeons in some of the less developed regions may also hamper the market growth during the forecast period.
Availability of Technically Advanced Equipment and Surge in Ligament Injuries Driving Demand in the United States Market
The United States dominates the North American market with a total market share of around 34.8% in 2023 and this trend is likely to continue even during the forecast period.
In contrast to other nations, the United States has more technically advanced equipment and a greater understanding of ligament and tendon regeneration using artificial materials. Additionally, the enhanced healthcare facilities in the United States support the availability of ligament augmentation procedures nationwide.
Rising obesity rates result in issues with the knee joints, which also contributes to the way the share of the market has grown in the country.
As per FMI, demand in the United States will grow steadily during the forecast period, owing to increased sports-related injuries, rising investments in sports medicine, the growing popularity of minimally invasive procedures, and a surge in hospital admissions.
Presence of Leading Ligament Augmentation Device Providers Propelling Growth in the United Kingdom and Germany
Germany and the United Kingdom are home to major manufacturers like Xiros Ltd, Corin Group, and Neoligaments. LARS ligaments are distributed in the United Kingdom by the Corin Group, Neoligaments) makes the PatellarTape System, Leeds-Keio ligament, and Jewel ACL products. The presence of these leading players is playing a key role in boosting the growth of ligament augmentation in these European nations.
These businesses also focus on expanding their local distribution networks, which could boost product penetration in the European market. In 2023, Germany's regional market share in the European market was about 3.5%, compared to the United Kingdom. 's value share of roughly 4.7%.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Demand for Artificial Tendons and Ligaments To Remain High in the Global Market
As per FMI, the artificial tendons and ligaments segment is expected to grow at the fastest CAGR of 6.2% during the forecast period (2023 to 2033). Compared to ligament augmentation devices, artificial tendons and ligament products are more reliable and provide patients with greater benefits.
Procedures with ligament augmentation devices involve inserting foreign material into the knee and could cause difficulties, especially in the immunocompromised and elderly age group, and may appear to have donor or site incompatibility. Thus, the artificial tendons and ligaments segment holds a greater market value share.
Hospitals to Remain the Most Remunerative Segment in the Global Ligament Augmentation Market
The hospital's segment held the highest market share value of 35.5% in the global market in 2023, and it is poised to grow steadily during the forecast period. This can be attributed to the rising preference of patients towards opting for these procedures in hospitals.
Hospitals are the primary places where complicated and technologically advanced surgical procedures are undertaken. Hence, the growing awareness about ligament augmentation surgical procedures and its increasing awareness in developing countries has made it a dominant end user.
Manufacturers compete on pricing by combining their products in economical packages. A rise in awareness has transformed the market's dynamics. Equipment manufacturers are starting to grow their businesses by making sizable investments in companies that manufacture ligament augmentation devices and artificial ligament and tendon replacement devices. Besides this, they are adopting strategies such as new product launches, partnerships, acquisitions, etc., to gain a competitive edge in the market.
For instance:
| Attribute | Details |
|---|---|
| Market Size (2023) | US$ 45.7 million |
| Projected Market Size (2033) | US$ 80.3 million |
| Anticipated Growth Rate (2023 to 2033) | 5.8% CAGR |
| Forecast Period | 2018 to 2022 |
| Historical Data Available for | 2023 to 2033 |
| Market Analysis | US$ million for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, North Africa, and South Africa |
| Key Market Segments Covered | Product, End User, and Region |
| Key Companies Profiled |
|
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
The global market is forecasted to grow at 5.8% CAGR through 2033.
The overall global market could reach a value of US$ 80.3 million by 2033.
The United States market accounted for 34.8% of the global market share in 2022.
The United Kingdom market could contribute significantly with a 4.7% CAGR through 2033.
Strykar, Arthrex, and Xiros are some popular companies in the global market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Artificial Tendons & Ligaments
5.3.2. Devices
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centres
6.3.3. Specialty Surgical Centres
6.3.4. Academic & Research Institutes
6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Product
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By End User
9.4. Key Takeaways
10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. UK
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Product
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By End User
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Product
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By End User
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Product
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By End User
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Product
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Product
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Product
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Product
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Product
15.4.2.2. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Product
15.5.2.2. By End User
15.6. UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Product
15.6.2.2. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Product
15.7.2.2. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Product
15.8.2.2. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Product
15.9.2.2. By End User
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Product
15.10.2.2. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Product
15.11.2.2. By End User
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Product
15.12.2.2. By End User
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Product
15.13.2.2. By End User
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Product
15.14.2.2. By End User
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Product
15.15.2.2. By End User
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Product
15.16.2.2. By End User
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Product
15.17.2.2. By End User
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Product
15.18.2.2. By End User
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Product
15.19.2.2. By End User
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Product
15.20.2.2. By End User
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Product
15.21.2.2. By End User
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2022
15.22.2.1. By Product
15.22.2.2. By End User
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2022
15.23.2.1. By Product
15.23.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Stryker Corporation
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Arthrex
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Corin Group
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Mathys AG Bettlach
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Orthomed S.A.S
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Zimmer Biomet
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Xiros Ltd
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Arthrosurface
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Smith & Nephew
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. ConMed Corporation
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Ligament Augmentation Market
